Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

WHEATON® Highlights Products at AACC 2014

Published: Thursday, July 24, 2014
Last Updated: Thursday, July 24, 2014
Bookmark and Share
The products to be featured at the meeting offer unique solutions for the clinical market.

WHEATON® today highlighted products to be featured at the 2014 AACC Annual Meeting that provide unique solutions addressing the specific needs of clinical laboratory and other clinical life sciences customers. These products showcase the company’s ongoing commitment to provide a range of distinctive products that provide solutions to the growing clinical testing sector.
 
WHEATON’S CryoElite Tissue Vials are designed for the safe, secure and effective cryopreservation of biological tissue specimens, which are essential for advances in biomedical research and have demanding requirements for cryogenic storage. They provide researchers a uniform vial able to maintain sample integrity while maximizing storage capacity and organization. CryoElite Tissue Vials were developed with input from industry thought leaders for the high performance tissue banking requirements of anatomical pathology departments, clinical trial organizations and biorepository and biobanking facilities. They offer researchers and clinicians who work with biological specimens ease of use, convenience and security for their precious samples.
 
MicroLiter Chromatography Vials are the industry’s most versatile and innovative, designed for high precision, trouble-free operation for both GC and HPLC applications. All MircroLiter Vials are Class 10,000 clean room packed, making them the clear choice for challenging clinical LOD and LOQ assays and limited quantity specimens and unknown targets.   A complete range of size and closure types are available, designed to the tightest tolerances to ensure that they exceed all autosampler specifications.  When high throughput applications require the use of glass vials, the MicroLiter MPSS allows for robotic liquid handling with the patented “uLmat” that eliminates leakage and cross contamination between wells.
 
Our line of High Recovery Vials has a unique patented interior bottom design, allowing for maximum retrieval of contents and enabling more tests to be conducted from a single vial, providing greater resource efficiency for in vitro diagnostics and diagnostic kits. They are designed for manual or automated handling and storage, and are especially useful for high value reagents and samples, reducing product waste by 99% and enabling full product retrieval without the need to overfill.
 
“We are investing substantial resources to better understand the specific needs of the clinical lab customer and create product solutions addressing those needs, by incorporating innovative, value-added features that help them do their jobs more effectively and efficiently,” said Wayne L. Brinster, CEO and President of WHEATON. “Our CryoElite Tissue Vials provide crucial performance advantages to the rapidly growing tissue banking field; our High Recovery Vials offer much-needed efficiencies to users of high value reagents; and our high precision, versatile, easy to use MicroLiter Chromatography Vials and other WHEATON specialty products show how our 125-year commitment to ongoing innovation and excellence help bring the benefits of scientific advances to our customers and all those they serve.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Wayne Brinster Joins WHEATON® as President
The company will continue its focus on supporting laboratory research, and packaging for diagnostics and specialty pharmaceutical markets.
Friday, October 26, 2012
Scientific News
Tracking Breast Cancer Before it Grows
A team of scientists led by University of Saskatchewan researcher Saroj Kumar is using cutting-edge Canadian Light Source techniques to screen and treat breast cancer at its earliest changes.
The Light of Fireflies for Medical Diagnostics
EPFL scientists have exploited the light of fireflies in a new method that detects biological molecules without the need for complex devices and high costs.
Could a simple saliva test detect Alzheimer's?
Researchers have presented findings suggesting that a simple, non-invasive diagnostic for Alzheimer's could be within reach.
Cheap Diagnostics with a Portable "Paper Machine"
Scientists have developed a cheap, portable system for point of care diagnostics for a range of infectious diseases, genetic conditions and cancer.
New Variant of Streptococcal Bacteria
Scientists have discovered a new variant of streptococcal bacteria that has contributed to a rise in disease cases in the UK over the last 17 years.
New Insights into “Antenna” of Human Cells
Scientists from the University of Leeds have uncovered the most comprehensive list yet of genes implicated in a group of common inherited diseases.
Discordant NIPT Test Results May Reflect Presence of Maternal Cancer
Results published in Journal of the American Medical Association.
Sperm RNA Test May Improve Evaluation of Male Infertility
To help resolve uncertainty—and guide prospective parents to the right fertility treatments—scientists propose the use of a new kind of fertility test. It involves examining sperm RNA by means of next-generation sequencing.
Optical 'Dog's Nose' Developed to Detect Cancer, Other Diseases
Researchers are using optical spectroscopy to develop a quick, non-invasive “breath test” they believe will have the potential to screen for a variety of diseases, including diabetes, infections and cancers.
Ebola Assays Compared in Head-to-Head Analysis
A newly published study has attempted to rigorously evaluate a few of the assays recently granted Emergency Use Authorization by the US Food and Drug Administration to test for Ebola Zaire virus.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!